Evidence map›Paper›PMID 25479605›Full record

ArticlePloS one2014

The pseudophosphatase MK-STYX induces neurite-like outgrowths in PC12 cells.

Brittany M Flowers, Lauren E Rusnak, Kristen E Wong, Dallas A Banks, Michelle R Munyikwa, Alexander G McFarland, Shantá D Hinton

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Understanding Pseudophosphatase Function Through Biochemical Interactions.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Article
  4. Article
  5. Pseudophosphatases as Regulators of MAPK Signaling.International journal of molecular sciences · 2021
    Review
  6. Article
  7. The Roles of Pseudophosphatases in Disease.International journal of molecular sciences · 2021
    Review
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Brittany M FlowersDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Lauren E RusnakDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Kristen E WongDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Dallas A BanksDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Michelle R MunyikwaDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Alexander G McFarlandDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
Shantá D HintonDepartment of Biology, Integrated Science Center, College of William and Mary, Williamsburg, VA, United States of America.
William & Mary · USWilliams (United States) · US

Funding

Howard Hughes Medical Institute
6 · The paper itself

Abstract

The rat pheochromocytoma PC12 cell line is a widely used system to study neuronal differentiation for which sustained activation of the extracellular signaling related kinase (ERK) pathway is required. Here, we investigate the function of MK-STYX [MAPK (mitogen-activated protein kinase) phosphoserine/threonine/tyrosine-binding protein] in neuronal differentiation. MK-STYX is a member of the MAPK phosphatase (MKP) family, which is generally responsible for dephosphorylating the ERKs. However, MK-STYX lacks catalytic activity due to the absence of the nucleophilic cysteine in the active site signature motif HC(X5)R that is essential for phosphatase activity. Despite being catalytically inactive, MK-STYX has been shown to play a role in important cellular pathways, including stress responses. Here we show that PC12 cells endogenously express MK-STYX. In addition, MK-STYX, but not its catalytically active mutant, induced neurite-like outgrowths in PC12 cells. Furthermore, MK-STYX dramatically increased the number of cells with neurite extensions in response to nerve growth factor (NGF), whereas the catalytically active mutant did not. MK-STYX continued to induce neurites in the presence of a MEK (MAP kinase kinase) inhibitor suggesting that MK-STYX does not act through the Ras-ERK/MAPK pathway but is involved in another pathway whose inactivation leads to neuronal differentiation. RhoA activity assays indicated that MK-STYX induced extensions through the Rho signaling pathway. MK-STYX decreased RhoA activation, whereas RhoA activation increased when MK-STYX was down-regulated. Furthermore, MK-STYX affected downstream players of RhoA such as the actin binding protein cofilin. The presence of MK-STYX decreased the phosphorylation of cofilin in non NGF stimulated cells, but increased its phosphorylation in NGF stimulated cells, whereas knocking down MK-STYX caused an opposite effect. Taken together our data suggest that MK-STYX may be a regulator of RhoA signaling, and implicate this pseudophosphatase as a regulator of neuronal differentiation.

Indexed as

AnimalsApoptosis Regulatory ProteinsCell DifferentiationMAP Kinase Signaling SystemMutationNeuritesPC12 CellsRatsrhoA GTP-Binding ProteinApoptosis Regulatory ProteinsrhoA GTP-Binding Protein

Identifiers

PMID25479605
PMCPMC4257672
OpenAlexW2049887250

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.